Switzerland· 9395016

Vi-De 3

A colecalciferol product, registered in Switzerland and dispensed under Swissmedic category D, on the national reimbursement list. The same ATC class is registered in 16 of our 19 countries.

Reimbursed in Switzerland (BAG SL)Cat D (Swissmedic)ATC A11CC05

Checked against BAG Spezialitätenliste (Switzerland) on

Informational only — not a medical device.

SOURCE REGISTER · CHBAG Spezialitätenliste (Switzerland)normalisedVi-De 3ATCA11CC05REGISTER NO.9395016PACKS LISTED1CHECKEDJune 4, 2026

Where it is registered

Colecalciferol is registered in 16 of 19 countries.

Countries holding a registration under ATC A11CC05 (colecalciferol), each read from that country’s own register.

  • This record: Switzerland, from BAG Spezialitätenliste (Switzerland)
  • 9 of them publish a price we can compare per daily dose

Colecalciferol · ATC A11CC05

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

BAG Spezialitätenliste (Switzerland)
Manufacturer
—
Country
Switzerland (CH)
ATC code
A11CC05
ATC class
Colecalciferol
Defined daily dose
20 mcg, O
Swissmedic category
D
Reimbursed
Yes
Source register
BAG Spezialitätenliste (Switzerland)
Last checked
June 4, 2026

Packs & prices · 1

1 priced
  • gtin
    7680093950166
    10 ml
    CHF 4.55

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

68 interactions on record for colecalciferol.

Graded by severity as the source publishes them — 10 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Colecalciferol · interactions on record

68 records

  • 10 severe
  • 56 moderate
  • 2 minor

Most severe, free to view

  • ErgocalciferolA11CC01severe
  • DihydrotachysterolA11CC02severe
  • CalcitriolA11CC04severe
  • CalcifediolA11CC06severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of BAG Spezialitätenliste (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ced4c744-e74f-4d9c-bfbd-75b5b1751ddd
GET /v1/drugs/ced4c744-e74f-4d9c-bfbd-75b5b1751ddd?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "unit": null,
  "strength": "cholecalciferolum (vitamin d3) 4500 UI",
  "valid_from": "2003-04-01",
  "limitations": "[{\"description\":\"Prophylaxe einer Rachitis während des ersten Lebensjahres, Therapie einer Rachitis oder Osteomalazie und Therapie bei nachgewiesenem schwerwiegendem Vitamin D-Mangel 25(OH)D-Konzentrationen <25 nmol/l oder 10 ng/ml.\",\"costApproval\":null,\"indication\":\"\",\"isNew\":false,\"limitationCode\":null,\"priceModel\":null,\"validFrom\":\"2025-01-01\"}]",
  "galenic_form": "Tropfen 4500 E/ml",
  "therapeutic_area": null,
  "sl_inclusion_date": "1955-03-15",
  "self_retention_pct": 10
}

See everything about colecalciferol.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.